EUVIMEDEUVIMED entdecken
Multizentrische Studie

Outcomes of endoscopic submucosal dissection for high-risk colorectal colitis-associated neoplasia in inflammatory bowel disease

Roberta Maselli, Roberto de Sire, Federico Barbaro, Paolo Cecinato iD, Gianluca Andrisani, Erik Rosa-Rizzotto, Sandro Sferrazza, Giancarla Fiori, Francesco Azzolini, Francesco Pugliese, Antonio Facciorusso iD, Marco Spadaccini und 14 weitere

Endoscopy · 01.06.2025 · 57 (06) · 658-666

DOI: 10.1055/a-2524-3553 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Endoscopy, erschienen am 01.06.2025. Verfasst von Roberta Maselli und 25 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology, Endoscopy Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy. Hauptthemen laut MEDLINE: Endoscopic Mucosal Resection, Colitis-Associated Neoplasms, Colorectal Neoplasms, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with inflammatory bowel disease (IBD) have an increased risk of colorectal cancer. High-risk colorectal colitis-associated neoplasia (HR-CAN) can be difficult to treat using traditional endoscopic resection methods. This study evaluated the outcomes of endoscopic submucosal dissection (ESD) in patients with IBD and HR-CANs.

Methods

This retrospective multicenter study consecutively included patients with IBD who were referred to expert Italian endoscopy centers for ESD or hybrid ESD (hESD) of HR-CANs. The main outcomes were rates of en bloc, R0, and curative resections, adverse events, local recurrence, metachronous lesions, and post-resection surgery. Kaplan–Meier method was used to analyze survival rates. Risk factors associated with the main outcomes were investigated by univariable analysis.

Results

91 patients with colonic IBD (disease duration 15.3 [SD 8.7] years, 82.4 % with ulcerative colitis) with 96 HR-CANs (mean size 34.8 [SD 16.2] mm, 53.1 % high grade dysplasia/adenocarcinoma) were included. ESD and hESD were performed in 82.3 % and 17.7 %, respectively. En bloc, R0, and curative resections were achieved in 95.8 % (95 %CI 89.6–98.8), 85.4 % (95 %CI 76.7–91.7), and 83.3 % (95 %CI 74.3–90.1). Adverse events occurred in 12.5 % (95 %CI 6.6–20.8), which were all conservatively managed. After a mean follow-up of 23.4 (SD 16.1) months, local recurrence and metachronous lesions each occurred in 3.1 %. Post-resection surgery was required in 11.5 %.

Conclusions

ESD of HR-CANs showed favorable outcomes on the medium- and long-term course in patients with IBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endoscopic Mucosal ResectionColitis-Associated NeoplasmsColorectal NeoplasmsInflammatory Bowel DiseasesAdenocarcinomaColitis, UlcerativeHumansMaleFemaleRetrospective StudiesMiddle AgedAdultTreatment OutcomeAgedNeoplasm Recurrence, LocalColonoscopyRisk FactorsItaly

Autor:innen und Institutionen

  • Gastroenterology, Endoscopy Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy.
  • Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
  • IBD Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy.
  • Digestive Endoscopy Unit, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy.
  • Digestive Endoscopy Unit, IRCCS Azienda Ospedaliera Universitaria di Bologna, Bologna, Italy.
  • Gastroenterology and Digestive Endoscopy, Azienda USL di Reggio Emilia, IRCCS, Reggio Emilia, Italy.

ORCID-Profile: Paolo Cecinato, Antonio Facciorusso, Antonio Capogreco

Zitieren

APA

Maselli, R., de Sire, R., Barbaro, F., Cecinato, P., Andrisani, G., Rosa-Rizzotto, E., Sferrazza, S., Fiori, G., Azzolini, F., Pugliese, F., Facciorusso, A., Spadaccini, M., Capogreco, A., Massimi, D., Alfarone, L., Chiappetta, M. F., Gubbiotti, A., Menini, M., Khalaf, K., …, & Endoscopic Resection Italian Network (ERIN) Group (2025). Outcomes of endoscopic submucosal dissection for high-risk colorectal colitis-associated neoplasia in inflammatory bowel disease. Endoscopy, 57(06), 658-666. https://doi.org/10.1055/a-2524-3553

Vancouver

Maselli R, de Sire R, Barbaro F, Cecinato P, Andrisani G, Rosa-Rizzotto E, et al. Outcomes of endoscopic submucosal dissection for high-risk colorectal colitis-associated neoplasia in inflammatory bowel disease. Endoscopy. 2025;57(06):658-666. doi:10.1055/a-2524-3553

BibTeX
@article{Maselli2025,
  author = {Maselli, Roberta and de Sire, Roberto and Barbaro, Federico and Cecinato, Paolo and Andrisani, Gianluca and Rosa-Rizzotto, Erik and Sferrazza, Sandro and Fiori, Giancarla and Azzolini, Francesco and Pugliese, Francesco and Facciorusso, Antonio and Spadaccini, Marco and Capogreco, Antonio and Massimi, Davide and Alfarone, Ludovico and Chiappetta, Michele Francesco and Gubbiotti, Alessandro and Menini, Maddalena and Khalaf, Kareem and Sassatelli, Romano and Di Matteo, Francesco Maria and Spada, Cristiano and Hassan, Cesare and Repici, Alessandro and Armuzzi, Alessandro and Endoscopic Resection Italian Network (ERIN) Group, Endoscopic Resection Italian Network (ERIN) Group},
  title = {Outcomes of endoscopic submucosal dissection for high-risk colorectal colitis-associated neoplasia in inflammatory bowel disease},
  journal = {Endoscopy},
  year = {2025},
  volume = {57},
  number = {06},
  pages = {658--666},
  doi = {10.1055/a-2524-3553}
}
Kostenlos starten →